Publications
Our publications
Citation
Measuring T-cell immunity in HIV vaccine clinical trials: PBMC and ELISPOT assay proficiency concordance in laboratories from 3 continents.
Clin Vaccine Immunol . 2008 Dec 17 ; | DOI : 10.1128/CVI.00326-08.
- M. Boaz
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
An in vitro-transcribed-mRNA polyepitope construct encoding 32 distinct HLA class I-restricted epitopes from CMV, EBV, and Influenza for use as a functional control in human immune monitoring studies.
J Immunol Methods . 2010 Jul 15 ; 360(1-2) 149 | DOI : 10.1016/j.jim.2010.07.003
- JS. Nielsen
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Reference
Epitope mapping of HIV-specific CD8+ T cell responses by multiple immunological readouts reveals distinct specificities defined by function.
J Virol . 2010 Nov 17 ; 85(3) 1275 | DOI : 10.1128/JVI.01707-10.
- ME. Richmond
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Shipping blood to a central laboratory in multicenter clinical trials: effect of ambient temperature on specimen temperature, and effects of temperature on mononuclear cell yield, viability and immunologic function.
J Transl Med . 2011 Mar 08 ; 9 26 | DOI : 10.1186/1479-5876-9-26
- WC. Olson
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Immunization with a poly (lactide co-glycolide) encapsulated plasmid DNA expressing antigenic regions of HPV 16 and 18 results in an increase in the precursor frequency of T cells that respond to epitopes from HPV 16, 18, 6 and 11.
Cellular Immunol . 2011 Apr 23 ; 270(1) 62 | DOI : 10.1016/j.cellimm.2011.04.005
- M. Matijevic
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
A Poxvirus vaccine is safe, induces T-Cell responses, and decreases viral load in patients with chronic Hepatitis C.
Gastroenterol . 2011 Jun 13 ; 141(3) 890 | DOI : 10.1053/j.gastro.2011.06.009
- F. Habersetzer
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
T-cell responses to hepatitis B splice-generated protein of hepatitis B virus and inflammatory cytokines/chemokines in chronic hepatitis B patients. ANRS study: HB EP 02 HBSP-FIBRO.
J Viral Hepatitis . 2012 Apr 19 ; 19(12) 872 | DOI : 10.1111/j.1365-2893.2012.01611.x.
- F. Bayard
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Identification of minimal human MHC-restricted CD8+ T-cell epitopes within the Plasmodium falciparum circumsporozoite protein (CSP).
Malaria J . 2013 Jun 05 ; 12 185 | DOI : 10.1186/1475-2875-12-185
- M. Sedegah
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
Transcutaneous immunization of healthy volunteers with an attenuated Listeria monocytogenes vaccine strain and cholera toxin adjuvant.
Vaccine . 2013 May 22 ; 31(32) 3257 | DOI : 10.1016/j.vaccine.2013.05.028
- EH. Eypper
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025
Citation
SOX2-specific adaptive immunity and response to immunotherapy in non-small cell lung cancer.
Oncoimmunol . 2013 Jun 10 ; 2(7) e25205 | DOI : 10.4161/onci.25205.
- KM. Dhodapkar
- et al
Products : CEF Control Peptide Pool - 16 mg — AS-61036-05 ; CEF Control Peptide Pool - 1 mg — AS-61036-003 ; CEF Control Peptide Pool - 8 mg — AS-61036-025